About Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
During the past decade, Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
According to Clinical.Site data, the most researched conditions in "Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)" are
"Hepatic Impairment" (1 trials) and "Renal Impairment" (1 trials). Many other conditions were trialed in "Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)" in a lesser frequency.
Clinical Trials Intervention Types at Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
Most popular intervention types in "Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Molnupiravir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
The vast majority of trials in "Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)" are
2 trials for "All" genders.
Clinical Trials Status at Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)
Currently, there are NaN active trials in "Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Thomas Jefferson University - Pharmacology and Experimental Therapeutics ( Site 0001), 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".